Abstract
Aims: To evaluate the protective effect of berberine on β-cell lipoapoptosis induced by palmitate and to explore the possible underlying mechanisms. Materials and methods: HIT-T15 pancreatic β-cells were divided into the following treatment groups: untreated controls; 100 μM berberine; 0.5 mM palmitate; 0.5 mM palmitate + 0.1 μM berberine; 0.5 mM palmitate + 1 μM berberine; 0.5 mM palmitate + 10 μM berberine; and 0.5 mM palmitate + 100 μM berberine. After 48 h, cell apoptosis was assessed by flow cytometry and the Hoechst 33258 fluorescent assay. Basal and glucose-stimulated insulin levels in culture medium were measured by radioimmunoassay. Peroxisome proliferator-activated receptor-γ (PPAR-γ) mRNA and protein levels were determined by real-time PCR and immunocytochemistry, respectively. Results: Apoptosis was significantly increased upon treatment with palmitate as compared to the untreated controls (p<0.0001). In addition, glucose-stimulated insulin secretion (GSIS), PPAR-γ mRNA and protein expression were significantly reduced in response to palmitate (p<0.0001); however, palmitate-induced apoptosis and reduction in PPAR-γ expression were reversed in response to berberine in a dose-dependent manner (p<0.05). Furthermore, there was a non-significant increase in GSIS with increasing berberine dose. Conclusion: Palmitate exerted lipotoxic effects on HIT-T15 cells, inducing apoptosis and reducing GSIS. Berberine reduced palmitate-induced lipoapoptosis and tended to increase GSIS in HIT-T15 cells, possibly through increased PPAR-γ expression.
Article PDF
Similar content being viewed by others
Avoid common mistakes on your manuscript.
References
Ward WK, Beard JC, Halter JB, Pfeifer MA, Porte D Jr. Pathophysiology of insulin secretion in non-insulin-dependent diabetes mellitus. Diabetes Care 1984, 7: 491–502.
Lou DJ, Yang YW. The lipotoxicity and β cell apoptosis. Foreign Medical Sciences (Section of Internal Medicine) 2006, 33: 401–4.
Girard J. Fatty acids and beta cells. Diabetes Metab 2000, 26 (Suppl 3): 6–9.
Lupi R, Del Guerra S, Marselli L, et al. Rosiglitazone prevents the impairment of human islet function induced by fatty acids: evidence for a role of PPARgamma2 in the modulation of insulin secretion. Am J Physiol Endocrinol Metab 2004, 286: E560–7.
Kawai T, Hirose H, Seto Y, et al. Troglitazone ameliorates lipotoxicity in the beta cell line INS-1 expressing PPAR gamma. Diabetes Res Clin Pract 2002, 56: 83–92.
Du YF, Yang LY. The protective effect of high expression of mouse PPAR-γ1 on β-cell damage mediated by free fatty acid. Zhong Hua Diabetes Journal 2005, 12: 296–301.
Misra A, Kumar S, Kishore VN, Kumar A. The role of lipids in the development of diabetic microvascular complications: implications for therapy. Am J Cardiovasc Drugs 2003, 3: 325–38.
Heikkinen S, Auwerx J and Argmann CA. PPARgamma in human and mouse physiology. Biochim Biophys Acta 2007, 1771: 999–1013.
Saitoh Y, Chun-ping C, Noma K, Ueno H, Mizuta M, Nakazato M. Pioglitazone attenuates fatty acid-induced oxidative stress and apoptosis in pancreatic beta-cells. Diabetes Obes Metab 2008, 10: 564–73.
Wyne KL. Free fatty acids and type 2 diabetes mellitus. Am J Med 115 (Suppl 8A): 29S–36S, 2003.
Leng SH, Lu FE, Xu LJ. Therapeutic effects of berberine in impaired glucose tolerance rats and its influence on insulin secretion. Acta Pharmacol Sin 2004, 25: 496–502.
Tang LQ, Wei W, Chen LM, Liu S. Effects of berberine on diabetes induced by alloxan and a high-fat/high-cholesterol diet in rats. J Ethnopharmacol 2006, 108: 109–15.
Zhang Y, Li X, Zou D, et al. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J Clin Endocrinol Metab 2008, 93: 2559–65.
Kong W, Wei J, Abidi P, et al. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat Med 2004, 10: 1344–51.
Ravnskjaer K, Boergesen M, Rubi B, et al. Peroxisome proliferator-activated receptor alpha (PPARalpha) potentiates, whereas PPARgamma attenuates, glucose-stimulated insulin secretion in pancreatic beta-cells. Endocrinology 2005, 146: 3266–76.
Dixon G, Nolan J, McClenaghan NH, Flatt PR, Newsholme P. Arachidonic acid, palmitic acid and glucose are important for the modulation of clonal pancreatic beta-cell insulin secretion, growth and functional integrity. Clin Sci (Lond) 2004, 106: 191–9.
Hao Y, Wang P, Wu J, Qiu QY. Effects of ginsenoside and berberine on secretion of immunosuppressive cytokines in lung carcinoma cell line PG. Zhong Xi Yi Jie He Xue Bao 2008, 6: 278–82.
Meeran SM, Katiyar S, Katiyar SK. Berberine-induced apoptosis in human prostate cancer cells is initiated by reactive oxygen species generation. Toxicol Appl Pharmacol 2008, 229: 33–43.
Kim JB, Lee KM, Ko E, et al. Berberine inhibits growth of the breast cancer cell lines MCF-7 and MDA-MB-231. Planta Med 2008, 74: 39–42.
Lin JP, Yang JS, Chang NW, et al. GADD153 mediates berberine-induced apoptosis in human cervical cancer Ca ski cells. Anticancer Res 2007, 27: 3379–86.
Lin CC, Yang JS, Chen JT, et al. Berberine induces apoptosis in human HSC-3 oral cancer cells via simultaneous activation of the death receptor-mediated and mitochondrial pathway. Anticancer Res 2007, 27: 3371–8.
Zheng L, Zhou Z, Tao D, Lan T. Protective effect of berberine on cardiac myocyte injured by ischemia-reperfusion. Sichuan Da Xue Xue Bao Yi Xue Ban 2003, 34: 452–4.
Xiao X, Liu J, Hu J, Li T, Zhang Y. Protective effect of protopine on the focal cerebral ischaemic injury in rats. Basic Clin Pharmacol Toxicol 2007, 101: 85–9.
Lin CY, Gurlo T, Haataja L, Hsueh WA, Butler PC. Activation of peroxisome proliferator-activated receptor-gamma by rosiglitazone protects human islet cells against human islet amyloid polypeptide toxicity by a phosphatidylinositol 3′-kinase-dependent pathway. J Clin Endocrinol Metab 2005, 90: 6678–86.
Ricote M, Li AC, Willson TM, Kelly CJ, Glass CK. The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation. Nature 1998, 391: 79–82.
Kharroubi I, Ladriere L, Cardozo AK, Dogusan Z, Cnop M, Eizirik DL. Free fatty acids and cytokines induce pancreatic beta-cell apoptosis by different mechanisms: role of nuclear factor-kappaB and endoplasmic reticulum stress. Endocrinology 2004, 145: 5087–96.
Coll T, Jove M, Rodriguez-Calvo R, et al. Palmitate-mediated down-regulation of peroxisome proliferator-activated receptor-gamma coactivator 1alpha in skeletal muscle cells involves MEK1/2 and nuclear factor-kappaB activation. Diabetes 2006, 55: 2779–87.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Gao, N., Zhao, T.Y. & Li, X.J. The protective effect of berberine on β-cell lipoapoptosis. J Endocrinol Invest 34, 124–130 (2011). https://doi.org/10.1007/BF03347042
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347042